Suppr超能文献

外泌体 miR-122-5p 通过下调. 抑制胃癌的致瘤性。

Exosomal miR-122-5p inhibits tumorigenicity of gastric cancer by downregulating .

机构信息

Department of Oncology, The First People's Hospital of Lanzhou City, Lanzhou, Gansu, China.

出版信息

Int J Biol Markers. 2021 Mar;36(1):36-46. doi: 10.1177/1724600821990677. Epub 2021 Mar 22.

Abstract

BACKGROUND

microRNAs (miRNAs) are non-coding RNAs with important roles in the progression of human cancers, including gastric cancer. Exosomes are extracellular vesicles, which could transfer numerous noncoding RNAs, such as miRNAs. Here, in our study, we intended to investigate the role of exosomal miR-122-5p in gastric cancer progression.

METHODS

Exosomes were isolated utilizing commercial kit or ultracentrifugation. Biomarkers of exosomes or epithelia-mesenchymal transition (EMT) were monitored by western blot. Expression levels of miR-122-5p and G-protein-coupled receptor kinase interacting protein-1 () were evaluated by quantitative reverse transcription-polymerase chain reaction (qRT-PCR) or western blot. Cell proliferation and apoptosis were assessed by colony formation assay, methyl thiazolyl tetrazolium assay and flow cytometry. Cell metastasis was evaluated via Transwell assay. The interaction between miR-122-5p and was validated by dual-luciferase reporter assay. Furthermore, tumor growth in vivo was detected by xenograft assay.

RESULTS

Exosomes were successfully isolated. MiR-122-5p was downregulated in exosomes derived from the serum of gastric cancer patients. Exosomal miR-122-5p could hinder gastric cancer cell proliferation and metastasis in vitro and tumor growth in vivo. Knockdown of also inhibited gastric cancer cell proliferation and metastasis. Exosomal miR-122-5p targeted to alter cellular behaviors of gastric cancer cells.

CONCLUSION

Exosomal miR-122-5p suppressed gastric cancer progression by targeting .

摘要

背景

微小 RNA(miRNAs)是在包括胃癌在内的人类癌症进展中起重要作用的非编码 RNA。外泌体是细胞外囊泡,可传递多种非编码 RNA,如 miRNAs。在这里,我们旨在研究外泌体 miR-122-5p 在胃癌进展中的作用。

方法

利用商业试剂盒或超速离心法分离外泌体。通过 Western blot 监测外泌体或上皮-间充质转化(EMT)的生物标志物。通过定量逆转录聚合酶链反应(qRT-PCR)或 Western blot 评估 miR-122-5p 和 G 蛋白偶联受体激酶相互作用蛋白-1()的表达水平。通过集落形成试验、甲基噻唑基四唑试验和流式细胞术评估细胞增殖和凋亡。通过 Transwell 试验评估细胞转移。通过双荧光素酶报告基因检测验证 miR-122-5p 与 之间的相互作用。此外,通过异种移植试验检测体内肿瘤生长情况。

结果

成功分离出外泌体。胃癌患者血清来源的外泌体中 miR-122-5p 下调。外泌体 miR-122-5p 可抑制体外胃癌细胞增殖和转移以及体内肿瘤生长。下调 也抑制胃癌细胞增殖和转移。外泌体 miR-122-5p 通过靶向 改变胃癌细胞的细胞行为。

结论

外泌体 miR-122-5p 通过靶向 抑制胃癌进展。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验